4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001628280-26-024098
President and CEO sold 72,559 shares at $9.16 ($664,350)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| De Backer Marianne President and CEO | 2026-04-06 | Sale 10b5-1 | −72,559 | $9.16 | $664,350 | 948,145 | D |
| Open-market sales · 72,559 sh · avg $9.16 · $664,350 | |||||||
Loading xslF345X06/wk-form4_1775595054.xml…